Startseite Naturwissenschaften Crystal structure of 4-cyclohexyl-5-(thiophen-2-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thione, C12H15N3S2
Artikel Open Access

Crystal structure of 4-cyclohexyl-5-(thiophen-2-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thione, C12H15N3S2

  • Lamya H. Al-Wahaibi ORCID logo , Olivier Blacque ORCID logo , Edward R. T. Tiekink ORCID logo und Ali A. El-Emam ORCID logo EMAIL logo
Veröffentlicht/Copyright: 27. Juni 2025
Artikel downloaden (PDF)
Veröffentlichen auch Sie bei De Gruyter Brill
Manuskript einreichen Informationen für Autor*innen
Zeitschrift für Kristallographie - New Crystal Structures
Aus der Zeitschrift Zeitschrift für Kristallographie - New Crystal Structures Band 240 Heft 5

Abstract

C12H15N3S2, monoclinic, P21/n (no. 14), a = 5.51310(10) Å, b = 15.4525(4) Å, c = 15.9261(4) Å, β = 99.844(2)°, V = 1336.79(5) Å3, Z = 4, R gt (F) = 0.0359, wR ref (F2) = 0.1009, T = 160 K.

CCDC no.: 2450625

1 Source of material

A mixture of thiophene-2-carbohydrazide (1.42 g, 0.01 mol) and cyclohexyl isothiocyanate (1.41 g, 0.01 mol), in ethanol (10 mL), was heated under reflux for 30 min, and the solvent was then distilled off under vacuum. Sodium hydroxide in a 10 % aqueous solution (8 mL) was then added to the residue, and the mixture was heated under reflux for 2 h, then filtered hot. On cooling, the mixture was acidified with hydrochloric acid (pH 1–2) and the precipitated crude product was filtered, washed with water, dried and crystallised from aqueous ethanol to yield 2.28 g (86 %) of the title compound as colourless prisms. Single crystals suitable for X-ray diffraction were obtained by slow evaporation of a solution of the title compound in EtOH/CHCl3 (2:1, v/v) held at room temperature for 2 days. M. pt: 469–471 K (uncorrected). 1H NMR (CDCl3, 500.13 MHz): δ 13.6 (s, 1H, NH), 6.98 (t, 1H, Thiophene–H, J = 4.2 Hz), 7.10 (d, 1H, Thiophene–H, J = 4.2 Hz), 7.18 (d, 1H, Thiophene–H, J = 4.2 Hz), 2.54–2.68 (m, 1H, Cyclohexyl–H), 1.50–1.72 (m, 4H, Cyclohexyl–H), 1.12–1.44 (m, 6H, Cyclohexyl–H). 13C NMR (CDCl3, 125.76 MHz): δ 169.26 (C=S), 148.66 (Triazole–C5), 124.62, 126.04, 127.88, 128.0 (Thiophene–C), 24.44, 25.98, 30.88, 66.62 (Cyclohexyl–C).

Table 1:

Data collection and handling.

Crystal: Colourless prism
Size: 0.22 × 0.11 × 0.05 mm
Wavelength:

μ:		 CuKα radiation (1.54184 Å)

3.46 mm−1
Diffractometer, scan mode:

θmax, completeness:		 Rigaku Synergy, ω scan

74.5°, 100 %
N(hkl)measured, N(hkl)unique, Rint: 14587, 2725, 0.051
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 2,403
N(param)refined: 196
Programs: Rigaku, 1 SHELX, 2 , 3 WinGX 4

2 Experimental details

The C-bound H atoms were geometrically placed (C–H = 0.95–1.00 Å) and refined as riding with Uiso(H) = 1.2Ueq(C). The N-bound H atom was refined freely. The S2-containing thiophen-2-yl ring was disordered over two co-planar orientations, each of which was refined independently. The major component of the disorder had a site occupancy factor = 0.544(2).

3 Discussion

The 1,2,4-triazole scaffold is recognised as an essential component of several biologically interesting drugs and exhibits a wide range of chemotherapeutic properties. 5 , 6 Marketed triazole-based drugs are extensively used as advantageous anti-fungal, 7 anti-cancer, 8 anti-bacterial 9 and anti-viral 10 agents. In addition, the thiophene heterocycle constitutes a main building block of many drugs. 11

The molecular structure of the title triazole-thiophene hybrid molecule, (I), is shown in figure (50 % probability ellipsoids; only the major component of the disordered S2-containing thiophen-2-yl ring is shown for reasons of clarity). The molecule comprises a central 1,2,4-triazole-3-thione group connected at the 4-position to a cyclohexyl ring, and at the 5-position to a thiophen-2-yl ring; the dihedral angle between the two five-membered rings is 35.9(3)° consistent with a splayed orientation. Within the 1,2,4-triazole ring, the lengthening of the formally C8–N3 [1.3041(19) Å] double bond and the shortening, for example, of the formally N2–N3 [1.3640(18) Å] and C8–N1 [1.3854(18) Å] single bonds indicate significant delocalisation of π-electron density over the constituent atoms.

In the crystallographic literature, there are two related N-alkyl structures available for comparison, namely alkyl = ethyl 12 and cyclohexyl, 13 hereafter (II) and (III), respectively. Each of (II) and (III) exhibit similar patterns in the bond lengths within the 1,2,4-triazole ring as for (I). The relative orientations of the five-membered rings differ, however. Thus, in (II) and (III), the dihedral angles are 13.53(12) and 6.19(7)°, respectively, indicating closer to co-planar orientations than for (I). This difference is likely to arise due to steric considerations in (I). The separation between the methine–C–H and the thiophen-2-yl–C–H atoms of the disordered component of the ring is 2.25 Å which would contract if a more co-planar orientation was adopted.

In the molecular packing, the most prominent intermolecular interactions correspond to amine–N–H⋯S(thione) hydrogen-bonding [N2–H2n⋯S1 i : H2n⋯S1 i  = 2.38(2) Å, N2⋯S1 i  = 3.2511(14) Å with angle at H2n = 169.1(19)° for symmetry operation (i) 2 − x, 1 − y, 1 − z]. The hydrogen bonds occur within a centrosymmetric aggregate through an eight-membered {⋯HNCS}2 synthon. Similar synthons are noted in the crystals of (II) and (III).

Corresponding author: Ali A. El-Emam, Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt, E-mail:

  1. Author contributions: All authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Conflict of interest: The authors declare no conflicts of interest.

  3. Research funding: This study was financially supported by the the Princess Nourah bint Abdulrahman University Researchers Supporting Project No. PNURSP2023R3, from the Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

References

1. Rigaku Oxford Diffraction. CrysalisPRO; Rigaku Corporation: Oxford, UK, 2024.Suche in Google Scholar

2. Sheldrick, G. M. A Short History of Shelx. Acta Crystallogr. 2008, A64, 112–122; https://doi.org/10.1107/S0108767307043930.Suche in Google Scholar PubMed

3. Sheldrick, G. M. Crystal Structure Refinement with Shelxl. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/S2053229614024218.Suche in Google Scholar PubMed PubMed Central

4. Farrugia, L. J. WinGX and ORTEP for Windows: an Update. J. Appl. Crystallogr. 2012, 45, 849–854; https://doi.org/10.1107/S0021889812029111.Suche in Google Scholar

5. Aggarwal, R.; Sumran, G. An Insight on Medicinal Attributes of 1,2,4-triazoles. Eur. J. Med. Chem. 2020, 205, 112652; https://doi.org/10.1016/j.ejmech.2020.112652.Suche in Google Scholar PubMed PubMed Central

6. Tratrat, C. 1,2,4-Triazole: a Privileged Scaffold for the Development of Potent Antifungal Agents – a Brief Review. Curr. Top. Med. Chem. 2020, 20, 2235–2258; https://doi.org/10.2174/1568026620666200704140107.Suche in Google Scholar PubMed

7. Lass-Flrl, C. Triazole Antifungal Agents in Invasive Fungal Infections. Drugs 2011, 71, 2405–2419; https://doi.org/10.2165/11596540-000000000-00000.Suche in Google Scholar PubMed

8. Wen, X.; Zhou, Y.; Zeng, J.; Liu, X. Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents. Curr. Top. Med. Chem. 2020, 20, 1441–1460; https://doi.org/10.2174/1568026620666200128143230.Suche in Google Scholar PubMed

9. Tian, G.; Song, Q.; Liu, Z.; Guo, J.; Cao, S.; Long, S. Recent Advances in 1,2,3- and 1,2,4-triazole Hybrids as Antimicrobials and their SAR: a Critical Review. Eur. J. Med. Chem. 2023, 259, 115603; https://doi.org/10.1016/j.ejmech.2023.115603.Suche in Google Scholar PubMed

10. Paeshuyse, J.; Dallmeier, K.; Neyts, J. Ribavirin for the Treatment of Chronic Hepatitis C Virus Infection: a Review of the Proposed Mechanisms of Action. Curr. Opin. Virol. 2011, 1, 590–598; https://doi.org/10.1016/j.coviro.2011.10.030.Suche in Google Scholar PubMed

11. Bozorov, K.; Nie, L. F.; Zhao, J.; Aisa, H. A. 2-Aminothiophene Scaffolds: Diverse Biological and Pharmacological Attributes in Medicinal Chemistry. Eur. J. Med. Chem. 2017, 140, 465–493; https://doi.org/10.1016/j.ejmech.2017.09.039.Suche in Google Scholar PubMed

12. Wawrzycka-Gorczyca, I.; Siwek, A. Synthesis, X-ray Crystal Structure and Theoretical Study of 4-Ethyl-5-(2-thienyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione; Structural Comparison with Its Aromatic Analogs. Z. Kristallogr. Cryst. Mater. 2011, 226, 861–868; https://doi.org/10.1524/zkri.2011.1444.Suche in Google Scholar

13. Al-Shehri, M. M.; El-Emam, A. A.; El-Brollosy, N. R.; Ng, S. W.; Tiekink, E. R. T. 4-Benzyl-3-(thiophen2yl)-4,5-dihydro-1H-1,2,4-triazole-5-thione. Acta Crystallogr., Sect. E:2013, 69, o697; https://doi.org/10.1107/S1600536813009501.Suche in Google Scholar PubMed PubMed Central

Received: 2025-05-22
Accepted: 2025-06-23
Published Online: 2025-06-27
Published in Print: 2025-10-27

© 2025 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of (S)-N-(10-((2,2-dimethoxyethyl)amino)-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide, C25H32N2O7
  4. The crystal structure of 6,6′-difluoro-3,3′-dimethyl-5,5′-di(10H-phenoxazin-10-yl)- [1,1′-biphenyl]-2,2′-dicarbonitrile, C40H24F2N4O2
  5. Crystal structure of poly[(di-ethylenediamine-κ2N,N′)cadmium(II) tetradedocyloxidohexavanadate] (V4+/V5+ = 2/1), C4H16CdN4O14V6
  6. The crystal structure of poly[bis(dimethylformamide-κ1N)-(μ4-2′,3,3″,5′-tetrakis(trifluoromethyl)-[1,1′:4′,1″-terphenyl]-4,4″-dicarboxylato-κ4 O,O′: O″,O‴)dicadmium(II)], C27H15CdF12NO5
  7. Crystal structure of bis(μ2-ferrocenylcarboxylato-O,O′)-(μ3-oxido-κ3O:O:O)-bis(μ2-salicyladoximato-κ2N,O,O′)-(μ2-isopropoxo)-tris(isopropoxy-κ1O trititanium(IV)), C48H55N2O13Fe2Ti3
  8. Crystal structure of 3-(diethylamino)-7,9,11-trimethyl-8-phenyl-6H,13H-12λ4,13λ4-chromeno[3′,4′:4,5]pyrrolo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-one, C28H26BF2N3O2
  9. The crystal structure of catena-poly[aqua-μ2-2-nitro-benzene-1,3-dicarboxylato-κ2O,O′)-(1,10-phenanthroline-κ2N,N′)-zinc(II)], C20H13N3O7Zn
  10. Crystal structure of poly[diaqua-{μ3-1-(3-carboxylatophenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylato-κ4O,O′:O′′:O′′′′}manganese(II)] hydrate
  11. Crystal structure of N′-((1-hydroxycyclohexyl)(phenyl)methyl)-2-methoxybenzohydrazide methanol solvate, C22H28N2O4
  12. The cocrystal of caffeic acid — progesterone — water (1/2/1), C51H70O9
  13. Crystal structure of (((oxido(quinolin-6-yl)methoxy)triphenyl-λ5-stibanyl)oxy)(quinolin-7-yl)methanolate
  14. Crystal structure of [(E)-6′-(diethylamino)-2-(2-(((E)-pyren-1-ylmethylene)amino)ethyl)-4′-(2-((E)-1,3,3-trimethylindolin-2-ylidene)ethylidene)-1′,2′,3′,4′-tetrahydrospiro[isoindoline-1,9′-xanthen]-3-one]-methanol, solvate C57H56N4O3
  15. The crystal structure of 1-(acridin-9-yl)pyrrolidine-2,5-dione, C17H22N2O2
  16. Crystal structure of N-(4-acetylphenyl)-2-(6-methoxynaphthalen-2-yl)propanamide, C22H21NO3
  17. The crystal structure of 5,10,15,20-tetrakis(4-(1H-1,2,4-triazol-1-yl)phenyl)porphyrin, C52H34N16
  18. Crystal structure of hexacarbonyl-μ2-[phenylmethanedithiolato-κ4S:S,S′:S′]diiron (Fe–Fe) C13H6Fe2O6S2
  19. Crystal structure of diiodo-bis(1-((2-propyl-1H-benzo[d]imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κ1N)cadmium(II), C34H34CdI2N10
  20. Crystal structure of (E)-(3-(3-bromophenyl)acryloyl)ferrocene, C19H15BrFeO
  21. Crystal structure of catena-poly(μ2-6-chloropyridine-2-carboxylato-κ3N,O:O′)(6-chloropyridine-2-carboxylato-κ2O,N)copper(II), C12H6Cl2N2O4Cu
  22. Crystal structure of poly[diaqua-μ 3-(5-(3,5-dicarboxy-2,4,6-trimethylbenzyl)-2,4,6-trimethylisophthalato)-κ 6O,O′:O″,O‴:O‴′,O‴″) terbium(III)-monohydrate], C23H28TbO12
  23. Crystal structure of (E)-2-(((5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)methylene)amino)-3′,6′-dihydroxyspiro[isoindoline-1,9′-xanthen]-3-one – ethanol (1/2), C35H33ClN4O6
  24. The crystal structure of 3-(5-amino-3-phenylisoxazol-4-yl)-4-chloro-3-hydroxyindolin-2-one, C17H12ClN3O3
  25. The crystal structure of dimethylammonium 4-[2-(4-fluorophenyl)-4, 5-diphenyl-1H-imidazol-1-yl]benzenesulfonate, C29H26FN3O3S
  26. Crystal structure of (R)-2-ammonio-3-((5-carboxypentyl)thio)propanoate
  27. Crystal structure of 4-cyclohexyl-5-(thiophen-2-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thione, C12H15N3S2
  28. The crystal structure of 4,6-bis(dimethylamino)-2-fluoroisophthalonitrile, C12H13FN4
  29. Hydrogen bonding in the crystal structure of nicotin-1,1′-dium tetrabromidomanganate(II)
  30. The crystal structure of bis(2-bromobenzyl)(2-((2-oxybenzylidene)amino)-4-methylpentanoato-κ3N, O,O′)tin(IV), C27H27Br2NO3Sn
  31. Crystal structure of (E)-(3-(p-tolyl)acryloyl)ferrocene, C20H18FeO
  32. Crystal structure of (E)-7-fluoro-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C21H22FN3O
  33. Crystal structure of (E)-7-methoxy-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C22H25N3O2
  34. The crystal structure of poly(bis(μ2-1,3,5-tri(1H-imidazol-1-yl)benzene-κ2N:N′)-(μ2-2,3,5,6-tetrafluoroterephthalato-κ2O:O′)-manganese(II), C38H24F4N12O4Mn
  35. Crystal structure of (3,4-dimethoxybenzyl)triphenylphosphonium bromide ethanol solvate, C29H32BrO3P
  36. Crystal structure of tetraethylammonium hydrogencarbonate – (diaminomethylene)thiourea – water (2/1/3)
  37. Crystal structure of N, N-Dimethyl-N′-tosylformimidamide, C10H14N2O2S
  38. The crystal structure of ethyl 2-methyl-5-oxo-4-(2-methoxyphenyl)-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C20H23N2O4
  39. Crystal structure of bis(μ2-1,5-bis[(E)-1-(2-hydroxyphenyl)ethylidene] thiocarbonohydrazide)-bis(dimethylformamide)-dizinc(II) dimethylformamide solvate, C40H46N10O6S2Zn2⋅C3H7NO
  40. Crystal structure of azido-κ1N{hydridotris(3-tert-butyl-5-methylpyrazol-1-yl)borato-κ3N,N′,N″}copper(II), C24H40BCuN9
  41. The crystal structure of fac-tricarbonyl(1,10-phenanthroline-κ2N,N′)-(azido-κ1N)rhenium(I), C15H8N5O3Re
  42. Crystal structure of 4-((triphenylphosphonio)methyl)pyridin-1-ium tetrachloridozincate(II), C24H22Cl4NPZn
https://doi.org/10.1515/ncrs-2025-0245
Creative Commons
BY 4.0

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of (S)-N-(10-((2,2-dimethoxyethyl)amino)-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide, C25H32N2O7
  4. The crystal structure of 6,6′-difluoro-3,3′-dimethyl-5,5′-di(10H-phenoxazin-10-yl)- [1,1′-biphenyl]-2,2′-dicarbonitrile, C40H24F2N4O2
  5. Crystal structure of poly[(di-ethylenediamine-κ2N,N′)cadmium(II) tetradedocyloxidohexavanadate] (V4+/V5+ = 2/1), C4H16CdN4O14V6
  6. The crystal structure of poly[bis(dimethylformamide-κ1N)-(μ4-2′,3,3″,5′-tetrakis(trifluoromethyl)-[1,1′:4′,1″-terphenyl]-4,4″-dicarboxylato-κ4 O,O′: O″,O‴)dicadmium(II)], C27H15CdF12NO5
  7. Crystal structure of bis(μ2-ferrocenylcarboxylato-O,O′)-(μ3-oxido-κ3O:O:O)-bis(μ2-salicyladoximato-κ2N,O,O′)-(μ2-isopropoxo)-tris(isopropoxy-κ1O trititanium(IV)), C48H55N2O13Fe2Ti3
  8. Crystal structure of 3-(diethylamino)-7,9,11-trimethyl-8-phenyl-6H,13H-12λ4,13λ4-chromeno[3′,4′:4,5]pyrrolo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-one, C28H26BF2N3O2
  9. The crystal structure of catena-poly[aqua-μ2-2-nitro-benzene-1,3-dicarboxylato-κ2O,O′)-(1,10-phenanthroline-κ2N,N′)-zinc(II)], C20H13N3O7Zn
  10. Crystal structure of poly[diaqua-{μ3-1-(3-carboxylatophenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylato-κ4O,O′:O′′:O′′′′}manganese(II)] hydrate
  11. Crystal structure of N′-((1-hydroxycyclohexyl)(phenyl)methyl)-2-methoxybenzohydrazide methanol solvate, C22H28N2O4
  12. The cocrystal of caffeic acid — progesterone — water (1/2/1), C51H70O9
  13. Crystal structure of (((oxido(quinolin-6-yl)methoxy)triphenyl-λ5-stibanyl)oxy)(quinolin-7-yl)methanolate
  14. Crystal structure of [(E)-6′-(diethylamino)-2-(2-(((E)-pyren-1-ylmethylene)amino)ethyl)-4′-(2-((E)-1,3,3-trimethylindolin-2-ylidene)ethylidene)-1′,2′,3′,4′-tetrahydrospiro[isoindoline-1,9′-xanthen]-3-one]-methanol, solvate C57H56N4O3
  15. The crystal structure of 1-(acridin-9-yl)pyrrolidine-2,5-dione, C17H22N2O2
  16. Crystal structure of N-(4-acetylphenyl)-2-(6-methoxynaphthalen-2-yl)propanamide, C22H21NO3
  17. The crystal structure of 5,10,15,20-tetrakis(4-(1H-1,2,4-triazol-1-yl)phenyl)porphyrin, C52H34N16
  18. Crystal structure of hexacarbonyl-μ2-[phenylmethanedithiolato-κ4S:S,S′:S′]diiron (Fe–Fe) C13H6Fe2O6S2
  19. Crystal structure of diiodo-bis(1-((2-propyl-1H-benzo[d]imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κ1N)cadmium(II), C34H34CdI2N10
  20. Crystal structure of (E)-(3-(3-bromophenyl)acryloyl)ferrocene, C19H15BrFeO
  21. Crystal structure of catena-poly(μ2-6-chloropyridine-2-carboxylato-κ3N,O:O′)(6-chloropyridine-2-carboxylato-κ2O,N)copper(II), C12H6Cl2N2O4Cu
  22. Crystal structure of poly[diaqua-μ 3-(5-(3,5-dicarboxy-2,4,6-trimethylbenzyl)-2,4,6-trimethylisophthalato)-κ 6O,O′:O″,O‴:O‴′,O‴″) terbium(III)-monohydrate], C23H28TbO12
  23. Crystal structure of (E)-2-(((5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)methylene)amino)-3′,6′-dihydroxyspiro[isoindoline-1,9′-xanthen]-3-one – ethanol (1/2), C35H33ClN4O6
  24. The crystal structure of 3-(5-amino-3-phenylisoxazol-4-yl)-4-chloro-3-hydroxyindolin-2-one, C17H12ClN3O3
  25. The crystal structure of dimethylammonium 4-[2-(4-fluorophenyl)-4, 5-diphenyl-1H-imidazol-1-yl]benzenesulfonate, C29H26FN3O3S
  26. Crystal structure of (R)-2-ammonio-3-((5-carboxypentyl)thio)propanoate
  27. Crystal structure of 4-cyclohexyl-5-(thiophen-2-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thione, C12H15N3S2
  28. The crystal structure of 4,6-bis(dimethylamino)-2-fluoroisophthalonitrile, C12H13FN4
  29. Hydrogen bonding in the crystal structure of nicotin-1,1′-dium tetrabromidomanganate(II)
  30. The crystal structure of bis(2-bromobenzyl)(2-((2-oxybenzylidene)amino)-4-methylpentanoato-κ3N, O,O′)tin(IV), C27H27Br2NO3Sn
  31. Crystal structure of (E)-(3-(p-tolyl)acryloyl)ferrocene, C20H18FeO
  32. Crystal structure of (E)-7-fluoro-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C21H22FN3O
  33. Crystal structure of (E)-7-methoxy-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C22H25N3O2
  34. The crystal structure of poly(bis(μ2-1,3,5-tri(1H-imidazol-1-yl)benzene-κ2N:N′)-(μ2-2,3,5,6-tetrafluoroterephthalato-κ2O:O′)-manganese(II), C38H24F4N12O4Mn
  35. Crystal structure of (3,4-dimethoxybenzyl)triphenylphosphonium bromide ethanol solvate, C29H32BrO3P
  36. Crystal structure of tetraethylammonium hydrogencarbonate – (diaminomethylene)thiourea – water (2/1/3)
  37. Crystal structure of N, N-Dimethyl-N′-tosylformimidamide, C10H14N2O2S
  38. The crystal structure of ethyl 2-methyl-5-oxo-4-(2-methoxyphenyl)-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C20H23N2O4
  39. Crystal structure of bis(μ2-1,5-bis[(E)-1-(2-hydroxyphenyl)ethylidene] thiocarbonohydrazide)-bis(dimethylformamide)-dizinc(II) dimethylformamide solvate, C40H46N10O6S2Zn2⋅C3H7NO
  40. Crystal structure of azido-κ1N{hydridotris(3-tert-butyl-5-methylpyrazol-1-yl)borato-κ3N,N′,N″}copper(II), C24H40BCuN9
  41. The crystal structure of fac-tricarbonyl(1,10-phenanthroline-κ2N,N′)-(azido-κ1N)rhenium(I), C15H8N5O3Re
  42. Crystal structure of 4-((triphenylphosphonio)methyl)pyridin-1-ium tetrachloridozincate(II), C24H22Cl4NPZn
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 26.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2025-0245/html
Button zum nach oben scrollen